series-a
Stage
2023
Founded
1
Investors
About
Noetik generates large-scale genomic, transcriptomic, and proteomic data to enable self-supervised AI models that identify novel targets and predict patient response in cancer immunotherapy.
Explore Noetik's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.